tiprankstipranks
Cellectar Biosciences (CLRB)
NASDAQ:CLRB

Cellectar Biosciences (CLRB) Balance Sheet

1,225 Followers

Cellectar Biosciences Balance Sheet

Cellectar Biosciences's total assets for Q4 2023 were $12.08M, an increase of 85.52% from the previous quarter. CLRB total liabilities were $13.43M for the fiscal quarter, a 92.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 12.08M$ 21.59M$ 37.20M$ 58.66M$ 12.25M
Total Liabilities
$ 13.43M$ 6.08M$ 4.16M$ 3.86M$ 3.19M
Total Equity Gross Minority
$ -6.03M$ 15.51M$ 183.94M$ 54.79M$ 9.06M
Total Capitalization
$ -862.04K$ 15.51M$ 33.05M$ 54.79M$ 9.06M
Preferred Stock Equity
---$ 20.04M$ 1.15M
Capital Lease Obligations
---$ 421.64K$ 527.53K
Currency in USD

Cellectar Biosciences Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis